Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.61 USD | +1.00% | -9.82% | -11.10% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.10% | 395M | |
+48.54% | 56.61B | |
+36.47% | 39.25B | |
-6.02% | 39.62B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
+0.38% | 12.2B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing